Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$2.28 - $10.53
Next Earnings Date
May 08 2025
Next Earnings Date
May 08 2025
Latest price
Market Cap | $2.37B |
EV | $3.01B |
Shares Outstanding | 882.47M |
Beta | -0.13 |
Analyst Rating | BUY |
Analyst Target Price | $13.00 |
P/E 2025E | - |
P/Revenue 2025E | 22.67x |
Revenue | 150.90% |
EPS | 12.80% |
Operating Cash Flow | -12.60% |
Free Cash Flow | -8.90% |
Revenue | 222.10% |
EPS | - |
Operating Cash Flow | 34.40% |
Free Cash Flow | - |
Gross Margin 2025E | 83.00% |
Net Profit Margin 2025E | -362.99% |
ROE 2025E | - |
ROCE 2024 | - |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
ImmunityBio, Inc.
IBRX
Sector
Healthcare
Industry
Biotechnology
CEO
Adcock, Richard
Employees
680
Website
immunitybio.comIPO Date
2015-07-28
Headquarters
3530 John Hopkins Court, San Diego, California, 92121, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved